Tetrandrine
- Generic Name
- Tetrandrine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C38H42N2O6
- CAS Number
- 518-34-3
- Unique Ingredient Identifier
- 29EX23D5AJ
- Indication
用于风湿痛、关节痛、神经痛。与小剂量放射合并用于肺癌；亦用于单纯硅肺I、II、III期及各期煤硅肺（尘肺病）。
- Associated Conditions
- -
- Associated Therapies
- -
Tetrandrine Tablets Used in Hospitalized Adults With COVID-19
- First Posted Date
- 2023-01-25
- Last Posted Date
- 2024-10-01
- Lead Sponsor
- Peking University Third Hospital
- Target Recruit Count
- 414
- Registration Number
- NCT05697029
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
Tetrandrine in the Treatment of Rheumatoid Arthritis
- First Posted Date
- 2022-02-18
- Last Posted Date
- 2022-02-18
- Lead Sponsor
- Peking University People's Hospital
- Target Recruit Count
- 240
- Registration Number
- NCT05245448
- Locations
- 🇨🇳
Peking University People's Hospital, Beijing, China
Tetrandrine Tablets Used in the Treatment of COVID-19
- First Posted Date
- 2020-03-16
- Last Posted Date
- 2020-03-16
- Lead Sponsor
- Henan Provincial People's Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT04308317
- Locations
- 🇨🇳
Tetrandrine Tablets, Jinhua, Zhejiang, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath